Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union WHITEHOUSE STATION ...

NEW YORK (Reuters) - Merck & Co Inc's fast growing diabetes drug Januvia proved effective in helping patients lower blood sugar in combination with Takeda's Actos, and when used along with insulin ...

Januvia (sitagliptin) is a prescription drug that’s used to treat type 2 diabetes in adults. The drug comes as an oral tablet. It’s usually taken once per day. Januvia is used in adults to treat type ...

Positive Opinion For Type 2 Diabetes Treatment, JANUVIA - First In New Class Of Oral Treatments Known As DPP-4 Inhibitors, European Union JANUVIA (sitagliptin), Merck, Sharp & Dohme's treatment for ...

(Reuters) - Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a ...

Expert Rev Endocrinol Metab. 2008;3(6):691-697. Elimination of sitagliptin occurs primarily via renal excretion (79%) and involves active tubular secretion. Sitagliptin is a substrate for human ...

Merck & Co., Inc MRK presented new data from two studies, evaluating its type II diabetes drug Januvia (sitagliptin) as a treatment option on type II diabetes patients, who initiate insulin therapy ...

Januvia (sitagliptin) is a prescription oral tablet that’s taken to help manage blood sugar levels in people with type 2 diabetes. Januvia can cause mild to serious side effects, such as headache. The ...

April 18 (UPI) --In comparing three classes of medication for type 2 diabetes, researchers found one class, which includes the drugs Onglyza, Janumet and Januvia, did not reduce the risk of death.

The Market Share for DPP-IV Inhibitors and GLP-1 Analogues Will Increase by 22 Percent Through 2019, According to Findings from Decision Resources BURLINGTON, Mass., Sept. 21 /PRNewswire/ -- Decision ...

FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in ...